Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TSBX will decline by -1.80% over the next 2 Weeks and hit $0.35 by Monday, August 25, 2025. In that time frame, TSBX's share price is expected to range between $0.34 and $0.36.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 25, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 22, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 21, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 20, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 19, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 18, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 15, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 14, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 13, 2025 | 0.34 | 0.35 | 0.36 |
| Aug 12, 2025 | 0.34 | 0.35 | 0.36 |
TSBX shares remained flat 0 in Monday, August 11, 2025's trading session, starting and closing at a previous close of $0.36 to move at $0.36. The stock demonstrated notable intraday movement (see TSBX's key stats for a full breakdown), fluctuating between $0.36 and $0.36, a 0 trading range. While recent weeks have seen some volatility, TSBX has managed to secure a +0.14% gain over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 0 shares changing hands, 283.8K fewer than the previous session. This amounted to $0.00 in total market activity.
Will TSBX Continue Its Upward Trend?
According to analyst ratings and projections for TSBX, Turnstone Biologics Corp. shares are anticipated to increase by +0.50%, potentially reaching $0.36 per share by August 25, 2025. Short-term technical indicators currently suggest a neutral sentiment for TSBX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the TSBX stock forecast, now is a good time to buy TSBX stock because its current trading price is +1.84% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TSBX covering social and institutional perspectives.
TSBX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TSBX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.25% to 49.48%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.99%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.23%, maintains a neutral outlook for the long term. Insights into TSBX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Turnstone Biologics Short-Term Forecasts
TSBX Forecast For Next 5 Days
Our algorithm anticipates Turnstone Biologics (TSBX) stock could hit $0.37 by Aug 22, 2025. This represents a +5.13% rise from today's price, following a +1.37% change over the past five days.
TSBX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Turnstone Biologics Corp. (TSBX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.36, which would mean a +1.41% increase from the current price of $0.36. Projections for this period range from a high of $0.38 to a low of $0.34.
TSBX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Turnstone Biologics's price over the next three months point to a drop. TSBX stock is expected to peak at $0.25 on May 22, 2026 before potentially dipping to $0.00 on Aug 07, 2026. On average, TSBX is likely to trade around $0.08 in the coming 90 days.
Turnstone Biologics Stock Forecast 2025
Based on our predictive models, Turnstone Biologics (TSBX) is expected to trade between $0.00 and $0.28 throughout 2026. This would result in an average price of $0.09, potentially offering investors a -74.65% return from current levels.
Turnstone Biologics Corp. Monthly Forecast 2025–2026
August 2025
According to our latest forecast models, Turnstone Biologics Corp. (TSBX) is positioned to show a strong performance in August 2025. The price is predicted to move between $0.21 and $0.50, settling at an average of $0.36. This could translate to a +1.41% gain.
September 2025
Based on current market signals, Turnstone Biologics Corp. is projected to trend september 2025. We forecast a trading range from $0.01 to $0.45, with a likely average price of $0.22. Investors could expect a potential return of -38.03%.
October 2025
Our predictive algorithms indicate Turnstone Biologics Corp. stock may see a shift in October 2025. The expected range spans $0.00–$0.35, with an average target of $0.17. This represents a cautious outlook and a possible loss of -52.11%.
November 2025
Analyzing established trends, Turnstone Biologics Corp. looks set to move in November 2025. Projections place the stock between $0.00 and $0.28, averaging around $0.06. This suggests a -83.10% loss from current levels.
December 2025
Market indicators suggest Turnstone Biologics Corp. could experience notable changes during December 2025. Prices could fluctuate within $0.00 to $0.29, with a midpoint forecast of $0.12. The stock might deliver a -66.20% loss.
January 2026
Forecasting for January 2026, models estimate that Turnstone Biologics Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.22, averaging $0.07. This signals a cautious trajectory with potential returns around -80.28%.
February 2026
According to our latest forecast models, Turnstone Biologics Corp. (TSBX) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $0.27, settling at an average of $0.10. This could translate to a -71.83% loss.
March 2026
Based on current market signals, Turnstone Biologics Corp. is projected to trend march 2026. We forecast a trading range from $0.01 to $0.28, with a likely average price of $0.14. Investors could expect a potential return of -60.56%.
April 2026
Our predictive algorithms indicate Turnstone Biologics Corp. stock may see a shift in April 2026. The expected range spans $0.00–$0.25, with an average target of $0.08. This represents a cautious outlook and a possible loss of -77.46%.
May 2026
Analyzing established trends, Turnstone Biologics Corp. looks set to move in May 2026. Projections place the stock between $0.00 and $0.25, averaging around $0.11. This suggests a -69.01% loss from current levels.
June 2026
Market indicators suggest Turnstone Biologics Corp. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $0.22, with a midpoint forecast of $0.07. The stock might deliver a -80.28% loss.
July 2026
Forecasting for July 2026, models estimate that Turnstone Biologics Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.20, averaging $0.07. This signals a cautious trajectory with potential returns around -80.28%.
August 2026
According to our latest forecast models, Turnstone Biologics Corp. (TSBX) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.19, settling at an average of $0.07. This could translate to a -80.28% loss.
TSBX's history of dividends and stock splits also plays a role in long-term investor confidence.

